Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Ono Pharmaceutical Co. (OPHLF) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$731.81M
Net Income	$152.15M
Cost of Goods Sold	$180.67M
Gross Profit	$551.14M
Operating Expenses	$538.69M
Operating Income	$193.12M
Non-Operating Income/Expense	$3.77M
Pre-Tax Income	$196.88M
Normalized Pre-Tax Income	$196.88M
Income after Taxes	$152.23M
Income from Continuous Operations	$152.23M
Consolidated Net Income/Loss	$152.23M
Normalized Income after Taxes	$152.23M
EBIT	$193.12M
EBITDA	$249.69M
Weighted-Average Shares Outstanding (Basic)	469.90M
Weighted-Average Shares Outstanding (Diluted)	469.90M
Earnings per Share (EPS) (Basic)	$0.32
Earnings per Share (EPS) (Diluted)	$0.32
Balance Sheet Financials
Current Assets	$2.75B
Property, Plant, and Equipment	$635.66M
Long-Term Assets	$4.08B
Total Assets	$6.83B
Current Liabilities	$837.65M
Long-Term Debt	$425.25M
Long-Term Liabilities	$495.89M
Total Liabilities	$1.33B
Common Equity	$5.50B
Tangible Shareholders Equity	$3.12B
Shareholders Equity	$5.50B
Common Shares Outstanding	469.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.63M
Cash Flow from Investing Activities	$21.56M
Cash Flow from Financial Activities	$-137.66M
Beginning Cash	$1.49B
End Cash	$1.38B
Increase/Decrease in Cash	$-110.28M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-110.07M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.12
Gross Margin	75.31%
Operating Margin	26.39%
EBIT Margin	26.39%
EBITDA Margin	--
Pre-Tax Profit Margin	26.90%
Profit Margin	20.79%
Free Cash Flow	$-5.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.51
Receiveable Turnover	0.89
Days Sales in Receivables	101.49
Return on Equity	2.77%
Return on Tangible Equity	4.88%
Return on Assets	2.23%
Return on Investments	2.57%
Book Value Per Share	$11.70
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$0.01

Data from Zacks Investment Research, Inc.